Walleye Trading’s Immunogen Inc IMGN Stock Holding History

Walleye Trading’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-86,400	Closed	-$2.56M	–	5620
2023 Q4	$2.56M	Buy	86,400 +82,100	+1,909%	+$1.63M	0.01%	1732
2023 Q3	$68.2K	Buy	4,300 +1,700	+65%	+$28.3K	﹤0.01%	4121
2023 Q2	$49.1K	Buy	+2,600	New	+$30.7K	﹤0.01%	3966
2022 Q2	–	Sell	-17,700	Closed	-$84K	–	5826
2022 Q1	$84K	Buy	17,700 +10,500	+146%	+$58.1K	﹤0.01%	4325
2021 Q4	$53K	Buy	+7,200	New	+$44.7K	﹤0.01%	4658
2019 Q1	–	Sell	-3,200	Closed	-$15K	–	4927
2018 Q4	$15K	Buy	3,200 +2,800	+700%	+$17K	﹤0.01%	4388
2018 Q3	$4K	Buy	+400	New	+$3.85K	﹤0.01%	5151

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Walleye Trading's IMGN Position: Q1 2024 in Review

Walleye Trading sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 12,812 shares — an estimated $380K sold.

Walleye Trading first reported a position in IMGN in Q2 2015 and held it in 14 quarters. The position peaked at $1.73M in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

Walleye Trading reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
Walleye Trading sold 12,812 Immunogen Inc shares in Q1 2024, an estimated $380K.
Walleye Trading first reported a position in Immunogen Inc in Q2 2015 and held it in 14 quarters.
Walleye Trading's Immunogen Inc position peaked at $1.73M in Q2 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.